Conference Coverage

Conference Coverage

Anti-Jo1 Predicts Improvement With Rituximab

Major Finding: Presence of the anti-synthetase autoantibody Jo-1 at baseline strongly predicted improvement in myositis patients taking rituximab...

Pages